It's hard going investing in biotech/biomed companies...There's...

It's hard going investing in biotech/biomed companies...There's no other way to say it...

In relation to prima biomed, we for so long were only concerned with CVAC, afterall that's
all we had. As it turned out, it worked and showed great results but prima couldn't take
it into production.....It was a great disappointment to long termers let alone a big hit
to their hip pockets.......Anyway, Marc Voight took us to an alternative with the acquisition
of Immutep and with it a highly credentialed scientist called Triebel, the preeminent
researcher into lag-3, Triebel managed to interest GSK and Novartis to partake in
his research in different disciplines and initiate trials in which robust effort is being
made, indeed one trial has been ramped up to almost double enrolees......
That's in other hands but we also have other trials initiated by prima that are
in early stages....I know it's disappointing but you can't expect too much market interest
until these trials show evidence of progressing further......

Whatever you may think about Prima Biomed you cannot say they aren't having a go....
There's money in the bank, there's things going on allover the place.....

I wish you all well......I feel good about this...